Literature DB >> 23946343

Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 induce different age-related metabolic profiles revealed by 1H-NMR spectroscopy in urine and feces of mice.

Elisa Brasili1, Elena Mengheri, Alberta Tomassini, Giorgio Capuani, Marianna Roselli, Alberto Finamore, Fabio Sciubba, Federico Marini, Alfredo Miccheli.   

Abstract

Age-related dysbioses of intestinal microbiota and decline in the overall metabolic homeostasis are frequently found in the elderly. Probiotic supplementation may represent a way to prevent or reduce the senescence-associated metabolic disorders. The present study evaluated the metabolic impact of Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 supplementation in relation to age by analyzing urine and feces metabolic profiles using (1)H-nuclear magnetic resonance spectroscopy and multivariate analysis. Adult (3 mo old) and aged (16 mo old) mice received an oral supplementation of the 2 probiotics (1 × 10(9) colony-forming units/d each) or phosphate buffered saline (control) daily for 30 d. Urine and feces were collected for 48 h before the end of the study. Partial least squares-discriminant analysis showed that the urinary discriminant metabolites for the probiotic treatment included higher dimethylglycine in adult and aged mice, lower sarcosine and nicotinate in adult mice, higher N-methylnicotinamide in adult mice and lower N-methylnicotinamide in aged mice compared with their controls. These results indicate a probiotic-induced modulation of homocysteine and NAD metabolism pathways, which have important implications because these pathways are involved in essential cellular processes that can be altered in senescence. The probiotic supplementation also modified the fecal metabolic profiles, inducing in both adult and aged mice higher 4-hydroxyphenylacetate and lower xylose in treated mice compared with their control mice, whereas valerate was greater in treated adult mice and lower in treated aged mice compared with their controls. The ANOVA simultaneous component analysis on urinary and fecal metabolic profiling showed an age × treatment interaction (P < 0.05), confirming the age-related modulation of the metabolic response to probiotic supplementation. The results suggest that L. acidophilus and B. lactis may prevent or reduce age-related metabolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23946343     DOI: 10.3945/jn.113.177105

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  16 in total

1.  Elevated muscle TLR4 expression and metabolic endotoxemia in human aging.

Authors:  Sangeeta Ghosh; Raweewan Lertwattanarak; Jose de Jesus Garduño; Joaquin Joya Galeana; Jinqi Li; Frank Zamarripa; Jack L Lancaster; Sumathy Mohan; Sophie Hussey; Nicolas Musi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05-20       Impact factor: 6.053

2.  Probiotic Properties and Cellular Antioxidant Activity of Lactobacillus plantarum MA2 Isolated from Tibetan Kefir Grains.

Authors:  Wei Tang; Chao Li; Zengguo He; Fen Pan; Shuo Pan; Yanping Wang
Journal:  Probiotics Antimicrob Proteins       Date:  2018-09       Impact factor: 4.609

3.  Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.

Authors:  A Miccheli; G Capuani; F Marini; A Tomassini; G Praticò; S Ceccarelli; D Gnani; G Baviera; A Alisi; L Putignani; V Nobili
Journal:  Int J Obes (Lond)       Date:  2015-03-26       Impact factor: 5.095

Review 4.  Importance of Diversity in the Oral Microbiota including Candida Species Revealed by High-Throughput Technologies.

Authors:  Tamaki Cho; Jun-Ichi Nagao; Rieko Imayoshi; Yoshihiko Tanaka
Journal:  Int J Dent       Date:  2014-04-22

5.  New insights into the impact of Lactobacillus population on host-bacteria metabolic interplay.

Authors:  Caroline I Le Roy; Jelena Štšepetova; Epp Sepp; Epp Songisepp; Sandrine P Claus; Marika Mikelsaar
Journal:  Oncotarget       Date:  2015-10-13

6.  Integrated Role of Bifidobacterium animalis subsp. lactis Supplementation in Gut Microbiota, Immunity, and Metabolism of Infant Rhesus Monkeys.

Authors:  Xuan He; Carolyn M Slupsky; James W Dekker; Neill W Haggarty; Bo Lönnerdal
Journal:  mSystems       Date:  2016-11-29       Impact factor: 6.496

7.  Combination of Metabolomic and Proteomic Analysis Revealed Different Features among Lactobacillus delbrueckii Subspecies bulgaricus and lactis Strains While In Vivo Testing in the Model Organism Caenorhabditis elegans Highlighted Probiotic Properties.

Authors:  Elena Zanni; Emily Schifano; Sara Motta; Fabio Sciubba; Claudio Palleschi; Pierluigi Mauri; Giuditta Perozzi; Daniela Uccelletti; Chiara Devirgiliis; Alfredo Miccheli
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640

8.  The Impact of Gluten Friendly Flour on the Functionality of an Active Drink: Viability of Lactobacillus acidophilus in a Fermented Milk.

Authors:  Barbara Speranza; Antonio Bevilacqua; Daniela Campaniello; Milena Sinigaglia; Daniela Musaico; Maria R Corbo; Carmela Lamacchia
Journal:  Front Microbiol       Date:  2018-08-30       Impact factor: 5.640

9.  Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment.

Authors:  Andrea Botticelli; Pamela Vernocchi; Federico Marini; Andrea Quagliariello; Bruna Cerbelli; Sofia Reddel; Federica Del Chierico; Francesca Di Pietro; Raffaele Giusti; Alberta Tomassini; Ottavia Giampaoli; Alfredo Miccheli; Ilaria Grazia Zizzari; Marianna Nuti; Lorenza Putignani; Paolo Marchetti
Journal:  J Transl Med       Date:  2020-02-03       Impact factor: 5.531

10.  Phylogenetic and Metabolic Tracking of Gut Microbiota during Perinatal Development.

Authors:  Federica Del Chierico; Pamela Vernocchi; Andrea Petrucca; Paola Paci; Susana Fuentes; Giulia Praticò; Giorgio Capuani; Andrea Masotti; Sofia Reddel; Alessandra Russo; Cristina Vallone; Guglielmo Salvatori; Elsa Buffone; Fabrizio Signore; Giuliano Rigon; Andrea Dotta; Alfredo Miccheli; Willem M de Vos; Bruno Dallapiccola; Lorenza Putignani
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.